PMC:7200337 / 91878-92140 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T527","span":{"begin":77,"end":85},"obj":"Disease"}],"attributes":[{"id":"A527","pred":"mondo_id","subj":"T527","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"To date, only one group has reported preliminary results from a cohort of 20 COVID-19 patients treated with a single administration of tocilizumab (400 mg, i.v.), along with lopinavir, methylprednisolone, and oxygen therapy (ChiCTR2000029765) (Xu et al., 2020b)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T958","span":{"begin":24,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T959","span":{"begin":62,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T960","span":{"begin":108,"end":109},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"To date, only one group has reported preliminary results from a cohort of 20 COVID-19 patients treated with a single administration of tocilizumab (400 mg, i.v.), along with lopinavir, methylprednisolone, and oxygen therapy (ChiCTR2000029765) (Xu et al., 2020b)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T295","span":{"begin":18,"end":23},"obj":"Chemical"},{"id":"T296","span":{"begin":135,"end":146},"obj":"Chemical"},{"id":"T297","span":{"begin":174,"end":183},"obj":"Chemical"},{"id":"T298","span":{"begin":185,"end":203},"obj":"Chemical"},{"id":"T299","span":{"begin":209,"end":215},"obj":"Chemical"}],"attributes":[{"id":"A295","pred":"chebi_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A296","pred":"chebi_id","subj":"T296","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A297","pred":"chebi_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A298","pred":"chebi_id","subj":"T298","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A299","pred":"chebi_id","subj":"T299","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"To date, only one group has reported preliminary results from a cohort of 20 COVID-19 patients treated with a single administration of tocilizumab (400 mg, i.v.), along with lopinavir, methylprednisolone, and oxygen therapy (ChiCTR2000029765) (Xu et al., 2020b)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3028","span":{"begin":0,"end":2},"obj":"Gene"},{"id":"3029","span":{"begin":86,"end":94},"obj":"Species"},{"id":"3038","span":{"begin":135,"end":146},"obj":"Chemical"},{"id":"3039","span":{"begin":174,"end":183},"obj":"Chemical"},{"id":"3040","span":{"begin":185,"end":203},"obj":"Chemical"},{"id":"3041","span":{"begin":209,"end":215},"obj":"Chemical"},{"id":"3046","span":{"begin":77,"end":85},"obj":"Disease"}],"attributes":[{"id":"A3028","pred":"tao:has_database_id","subj":"3028","obj":"Gene:6999"},{"id":"A3029","pred":"tao:has_database_id","subj":"3029","obj":"Tax:9606"},{"id":"A3038","pred":"tao:has_database_id","subj":"3038","obj":"MESH:C502936"},{"id":"A3039","pred":"tao:has_database_id","subj":"3039","obj":"MESH:D061466"},{"id":"A3040","pred":"tao:has_database_id","subj":"3040","obj":"MESH:D008775"},{"id":"A3041","pred":"tao:has_database_id","subj":"3041","obj":"MESH:D010100"},{"id":"A3046","pred":"tao:has_database_id","subj":"3046","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To date, only one group has reported preliminary results from a cohort of 20 COVID-19 patients treated with a single administration of tocilizumab (400 mg, i.v.), along with lopinavir, methylprednisolone, and oxygen therapy (ChiCTR2000029765) (Xu et al., 2020b)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T522","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To date, only one group has reported preliminary results from a cohort of 20 COVID-19 patients treated with a single administration of tocilizumab (400 mg, i.v.), along with lopinavir, methylprednisolone, and oxygen therapy (ChiCTR2000029765) (Xu et al., 2020b)."}